NCT02304770View on ClinicalTrials.gov

Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Cervical Persistent High Risk HPV InfectionCervical Intraepithelial Neoplasia
Interventions
DRUG

Aminolaevulinic acid photodynamic therapy

Aminolaevulinic acid mediated photodynamic therapy

Trial Locations (4)

200011

The Obstetrics & Gynecology Hospital of Fudan University, Shanghai

210036

The First Affliated Hospital with Nanjing Medical University, Nanjing

250012

Qilu Hospital of Shandong University, Jinan

310006

Women's Hospital School of Medicine Zhejiang University, Hangzhou

All Listed Sponsors
lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY

NCT02304770 - Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia | Biotech Hunter | Biotech Hunter